Recent News

• 02.13.2025 - InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
• 02.04.2025 - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 01.21.2025 - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 12.12.2024 - InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
• 12.09.2024 - InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
• 12.09.2024 - InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

Recent Filings

• 02.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities